- ↑ Philipp vonP. Rosenstiel Philipp vonP., Brivaracetam (UCB 34714), „Neurotherapeutics”, 4 (1), 2007, s. 84–87, DOI: 10.1016/j.nurt.2006.11.004, PMID: 17199019 .
- ↑ MarcoM. Mula MarcoM., Brivaracetam for the treatment of epilepsy in adults, „Expert Review of Neurotherapeutics”, 14 (4), 2014, s. 361–365, DOI: 10.1586/14737175.2014.896200, PMID: 24625006 .
- ↑ Nathalie T.N.T. Sanon Nathalie T.N.T. i inni, Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model, „Epilepsy & Behavior”, 79, 2018, s. 117–125, DOI: 10.1016/j.yebeh.2017.11.019, PMID: 29287214 .
- ↑ Briviact [online], European Medicines Agency [dostęp 2018-04-09] [zarchiwizowane z adresu 2016-06-10] (ang.).